These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 37236211)

  • 1. Neuroimaging standards for research into small vessel disease-advances since 2013.
    Duering M; Biessels GJ; Brodtmann A; Chen C; Cordonnier C; de Leeuw FE; Debette S; Frayne R; Jouvent E; Rost NS; Ter Telgte A; Al-Shahi Salman R; Backes WH; Bae HJ; Brown R; Chabriat H; De Luca A; deCarli C; Dewenter A; Doubal FN; Ewers M; Field TS; Ganesh A; Greenberg S; Helmer KG; Hilal S; Jochems ACC; Jokinen H; Kuijf H; Lam BYK; Lebenberg J; MacIntosh BJ; Maillard P; Mok VCT; Pantoni L; Rudilosso S; Satizabal CL; Schirmer MD; Schmidt R; Smith C; Staals J; Thrippleton MJ; van Veluw SJ; Vemuri P; Wang Y; Werring D; Zedde M; Akinyemi RO; Del Brutto OH; Markus HS; Zhu YC; Smith EE; Dichgans M; Wardlaw JM
    Lancet Neurol; 2023 Jul; 22(7):602-618. PubMed ID: 37236211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.
    Wardlaw JM; Smith EE; Biessels GJ; Cordonnier C; Fazekas F; Frayne R; Lindley RI; O'Brien JT; Barkhof F; Benavente OR; Black SE; Brayne C; Breteler M; Chabriat H; Decarli C; de Leeuw FE; Doubal F; Duering M; Fox NC; Greenberg S; Hachinski V; Kilimann I; Mok V; Oostenbrugge Rv; Pantoni L; Speck O; Stephan BC; Teipel S; Viswanathan A; Werring D; Chen C; Smith C; van Buchem M; Norrving B; Gorelick PB; Dichgans M;
    Lancet Neurol; 2013 Aug; 12(8):822-38. PubMed ID: 23867200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor image segmentation of the cerebrum provides a single measure of cerebral small vessel disease severity related to cognitive change.
    Williams OA; Zeestraten EA; Benjamin P; Lambert C; Lawrence AJ; Mackinnon AD; Morris RG; Markus HS; Charlton RA; Barrick TR
    Neuroimage Clin; 2017; 16():330-342. PubMed ID: 28861335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Whole Picture: From Isolated to Global MRI Measures of Neurovascular and Neurodegenerative Disease.
    Dickie DA; Quinn TJ; Dawson J
    Adv Exp Med Biol; 2019; 1205():25-53. PubMed ID: 31894568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into cerebral small vessel disease and vascular cognitive impairment from MRI.
    Smith EE; Beaudin AE
    Curr Opin Neurol; 2018 Feb; 31(1):36-43. PubMed ID: 29084064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractal dimension of cerebral white matter: A consistent feature for prediction of the cognitive performance in patients with small vessel disease and mild cognitive impairment.
    Pantoni L; Marzi C; Poggesi A; Giorgio A; De Stefano N; Mascalchi M; Inzitari D; Salvadori E; Diciotti S
    Neuroimage Clin; 2019; 24():101990. PubMed ID: 31491677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the contribution and strategic distribution patterns of neuroimaging features of small vessel disease in poststroke cognitive impairment.
    Shi L; Zhao L; Yeung FK; Wong SY; Chan RKT; Tse MF; Chan SC; Kwong YC; Li KC; Liu K; Abrigo JM; Lau AYL; Wong A; Lam BYK; Leung TWH; Fu J; Chu WCW; Mok VCT
    J Neurol Neurosurg Psychiatry; 2018 Sep; 89(9):918-926. PubMed ID: 29666204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Texture Analysis of T1-Weighted and Fluid-Attenuated Inversion Recovery Images Detects Abnormalities That Correlate With Cognitive Decline in Small Vessel Disease.
    Tozer DJ; Zeestraten E; Lawrence AJ; Barrick TR; Markus HS
    Stroke; 2018 Jul; 49(7):1656-1661. PubMed ID: 29866751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
    Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral small vessel disease: Recent advances and future directions.
    Markus HS; de Leeuw FE
    Int J Stroke; 2023 Jan; 18(1):4-14. PubMed ID: 36575578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural network efficiency predicts cognitive decline in cerebral small vessel disease.
    Boot EM; Mc van Leijsen E; Bergkamp MI; Kessels RPC; Norris DG; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2020; 27():102325. PubMed ID: 32622317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural network changes in cerebral small vessel disease.
    Tuladhar AM; Tay J; van Leijsen E; Lawrence AJ; van Uden IWM; Bergkamp M; van der Holst E; Kessels RPC; Norris D; Markus HS; De Leeuw FE
    J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):196-203. PubMed ID: 31744851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study.
    Lawrence AJ; Patel B; Morris RG; MacKinnon AD; Rich PM; Barrick TR; Markus HS
    PLoS One; 2013; 8(4):e61014. PubMed ID: 23613774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between total MRI-visible small vessel disease burden and domain-specific cognitive abilities in a community-dwelling older-age cohort.
    Hamilton O; Cox SR; Ballerini L; Bastin ME; Corley J; Gow AJ; Muñoz Maniega S; Redmond P; Valdés Hernández MDC; Wardlaw JM; Deary IJ
    Neurobiol Aging; 2021 Sep; 105():25-34. PubMed ID: 34022536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in rich club organization and cognition in cerebral small vessel disease.
    van Leijsen EMC; van Uden IWM; Bergkamp MI; van der Holst HM; Norris DG; Claassen JAHR; Kessels RPC; de Leeuw FE; Tuladhar AM
    Neuroimage Clin; 2019; 24():102048. PubMed ID: 31706220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of neuroimaging markers of cerebral small vessel disease with short-term outcomes in patients with minor cerebrovascular events.
    Chen X; Wang L; Jiang J; Gao Y; Zhang R; Zhao X; Shen T; Dai Q; Li J
    BMC Neurol; 2021 Jan; 21(1):21. PubMed ID: 33441129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified cerebral small vessel disease score is associated with vascular cognitive impairment after lacunar stroke.
    Zhi N; Zhang L; Wang Y; Bai S; Geng J; Yu L; Cao W; Zhuang L; Zhou Y; Guan Y
    Aging (Albany NY); 2021 Feb; 13(7):9510-9521. PubMed ID: 33535189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease.
    Heiss WD
    J Nucl Med; 2018 Nov; 59(11):1660-1664. PubMed ID: 29959217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale, design and methodology of the image analysis protocol for studies of patients with cerebral small vessel disease and mild stroke.
    Valdés Hernández Mdel C; Armitage PA; Thrippleton MJ; Chappell F; Sandeman E; Muñoz Maniega S; Shuler K; Wardlaw JM
    Brain Behav; 2015 Dec; 5(12):e00415. PubMed ID: 26807340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual markers of cerebral small vessel disease and domain-specific quality of life deficits.
    Fernando J; Brown RB; Edwards H; Egle M; Markus HS; Tay J
    Brain Behav; 2021 May; 11(5):e02106. PubMed ID: 33751852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.